Kivihall A, Aab A, Soja J, Sladek K, Sanak M, Altraja A
Clin Transl Allergy. 2019; 9:62.
PMID: 31798831
PMC: 6880603.
DOI: 10.1186/s13601-019-0301-8.
Janjua S, Schmidt S, Ferrer M, Cates C
Cochrane Database Syst Rev. 2019; 9:CD006924.
PMID: 31553802
PMC: 6760886.
DOI: 10.1002/14651858.CD006924.pub4.
Hanania N, Sethi S, Koltun A, Ward J, Spanton J, Ng D
Int J Chron Obstruct Pulmon Dis. 2019; 14:117-127.
PMID: 30643398
PMC: 6311322.
DOI: 10.2147/COPD.S173595.
Morina N, Haliti A, Iljazi A, Islami D, Bexheti S, Bozalija A
Open Access Maced J Med Sci. 2018; 6(5):777-781.
PMID: 29875845
PMC: 5985875.
DOI: 10.3889/oamjms.2018.187.
Raissy H, Kelly H
Drug Saf. 2016; 40(3):201-210.
PMID: 27928727
DOI: 10.1007/s40264-016-0483-0.
Adolescent Asthma Pharmacotherapy in a State of Flux.
Raissy H, Blake K
Pediatr Allergy Immunol Pulmonol. 2015; 28(3):187-190.
PMID: 26421215
PMC: 4580303.
DOI: 10.1089/ped.2015.0562.
Efficacy of acupuncture for chronic asthma: study protocol for a randomized controlled trial.
Yin L, Wang Y, Fan L, Xu Y, Wang W, Liu Y
Trials. 2015; 16:424.
PMID: 26399399
PMC: 4581041.
DOI: 10.1186/s13063-015-0947-z.
Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.
Dissanayake S
AAPS J. 2015; 17(3):754-7.
PMID: 25712726
PMC: 4406964.
DOI: 10.1208/s12248-015-9734-8.
Asthma pharmacogenetics and the development of genetic profiles for personalized medicine.
Ortega V, Meyers D, Bleecker E
Pharmgenomics Pers Med. 2015; 8:9-22.
PMID: 25691813
PMC: 4325626.
DOI: 10.2147/PGPM.S52846.
Assessing the risks and benefits of step-down asthma care: a case-based approach.
Hagan J, Rank M
Curr Allergy Asthma Rep. 2015; 15(8):503.
PMID: 25687171
DOI: 10.1007/s11882-014-0503-z.
Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.
Beasley R, Donohue J, Mehta R, Nelson H, Clay M, Moton A
BMJ Open. 2015; 5(2):e006131.
PMID: 25649209
PMC: 4322191.
DOI: 10.1136/bmjopen-2014-006131.
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD.
Donohue J, Hanania N, Make B, Miles M, Mahler D, Curry L
Chest. 2014; 146(6):1531-1542.
PMID: 25451347
PMC: 4251615.
DOI: 10.1378/chest.14-0117.
Empowering the child and caregiver: yellow zone Asthma Action Plan.
Dinakar C, Portnoy J
Curr Allergy Asthma Rep. 2014; 14(11):475.
PMID: 25183364
DOI: 10.1007/s11882-014-0475-z.
Orphan therapies: making best use of postmarket data.
Maro J, Brown J, Dal Pan G, Li L
J Gen Intern Med. 2014; 29 Suppl 3:S745-51.
PMID: 25029972
PMC: 4124121.
DOI: 10.1007/s11606-014-2882-1.
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
Ortega V, Hawkins G, Moore W, Hastie A, Ampleford E, Busse W
Lancet Respir Med. 2014; 2(3):204-13.
PMID: 24621682
PMC: 4053167.
DOI: 10.1016/S2213-2600(13)70289-3.
Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates C, Wieland L, Oleszczuk M, Kew K
Cochrane Database Syst Rev. 2014; (2):CD010314.
PMID: 24504983
PMC: 7087438.
DOI: 10.1002/14651858.CD010314.pub2.
Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
Ortega V, Meyers D
J Allergy Clin Immunol. 2013; 133(1):16-26.
PMID: 24369795
PMC: 3933289.
DOI: 10.1016/j.jaci.2013.10.040.
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.
Bateman E, OByrne P, Busse W, Lotvall J, Bleecker E, Andersen L
Thorax. 2013; 69(4):312-9.
PMID: 24253831
PMC: 3963539.
DOI: 10.1136/thoraxjnl-2013-203600.
Moderate aerobic exercise alters migration patterns of antigen specific T helper cells within an asthmatic lung.
Dugger K, Chrisman T, Jones B, Chastain P, Watson K, Estell K
Brain Behav Immun. 2013; 34:67-78.
PMID: 23928286
PMC: 3826814.
DOI: 10.1016/j.bbi.2013.07.011.
Pharmacogenetics and the development of personalized approaches for combination therapy in asthma.
Miller S, Ortega V
Curr Allergy Asthma Rep. 2013; 13(5):443-52.
PMID: 23912588
PMC: 3878163.
DOI: 10.1007/s11882-013-0372-x.
